SGW

Device To Detect Antibodies To Hepatitis D Virus

产品代码
SGW
器械名称
Device To Detect Antibodies To Hepatitis D Virus
管理类别
第 2 类(Class II)
21 CFR 条款
21 CFR 866.3176
FDA 专业组
Immunology
上市路径
需提交 510(k) 上市前通告
该代码近三年的 510(k)
1 件
其中 Summary 已存档
0 份,可直接下载
FDA 历史累计 510(k)
1 件(全部年份;本站只收录近三年的明细)

FDA 分类定义

The device to detect antibodies to hepatitis D Virus is an in vitro diagnostic device intended for prescription use for the detection of antibodies to the hepatitis D virus (anti-HDV) in human clinical specimens. The assay is intended as an aid in the diagnosis of HDV infection in individuals who are at risk for HDV infection. The assay is intended as an aid in diagnosis in conjunction with clinical findings and other diagnostic procedures. The assay is not intended for screening of blood, plasma, cells, or tissue donors.

定义原文来自 FDA 器械分类库,属美国联邦政府作品(公有领域)。

该代码近三年的 510(k)(1 件)

数据窗口为最近三年。最新一件:2025-12-23。

510(k) 号批准日期申请人器械名称摘要
DEN2500322025-12-23DiaSorin, Inc.LIAISON® XL MUREX Anti-HDV (318260); LIAISON® XL MUR
FDA 官方分类页: SGW
分类与上市路径以 FDA 现行公告为准。本页数据来自 openFDA(CC0 公有领域),不构成注册策略建议。